Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Apr 10;102(2):139-47.
doi: 10.1007/BF00234571.

Evidence that specific high mannose structures directly regulate multiple cellular activities

Affiliations

Evidence that specific high mannose structures directly regulate multiple cellular activities

N Sathyamoorthy et al. Mol Cell Biochem. .

Abstract

Previous studies have demonstrated that much of the immunomodulatory activity of the glycoprotein uromodulin can be attributed to attached oligosaccharides. Structural studies of isolated and purified saccharides derived from uromodulin suggest that the structure Man6GlcNAc2-asn can inhibit in vitro assays of antigen driven T cell proliferation. Based on these observations, we isolated a series of high mannose glycopeptides from a variety of natural sources and tested them for biological activity in a number of assays. We found that purified mannose rich glycopeptides are able to activate the hexose monophosphate (HMP) shunt, induce prostaglandin synthesis, and directly stimulate IL-1 synthesis. These in vitro effects appear to have in vivo counterparts. Thus in a species-restricted fashion, high mannose compounds are able to directly activate a delayed mononuclear cell infiltrate after intradermal injection. Our data suggest that specific mannose oligosaccharides may activate as well as inhibit cellular immune responses at several different levels. These findings support the hypothesis that specific saccharide structures could participate in the physiologic regulation of the immune response.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1989 Aug 1;49(15):4109-13 - PubMed
    1. J Clin Invest. 1976 Feb;57(2):319-28 - PubMed
    1. Int J Immunopharmacol. 1989;11(7):761-9 - PubMed
    1. Science. 1989 Mar 3;243(4895):1160-5 - PubMed
    1. Immunopharmacology. 1988 Jan-Feb;15(1):11-9 - PubMed

MeSH terms

LinkOut - more resources